Observational studyIndian heart journal

Efficacy and safety of the intensive dose of rosuvastatin 40mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease-ROSUVEES-2.

Chetan P Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.